-+ 0.00%
-+ 0.00%
-+ 0.00%

Aurinia Pharmaceuticals holds annual shareholder meeting

PUBT·06/04/2026 20:19:30
Listen to the news
Aurinia Pharmaceuticals holds annual shareholder meeting
  • Aurinia Pharmaceuticals held its annual general meeting on June 3, 2026.
  • Shareholders selected five directors to serve on the board until the 2027 annual meeting.
  • Shareholders ratified PricewaterhouseCoopers LLP as independent registered public accounting firm through the 2027 annual meeting.
  • Shareholders backed a non-binding advisory resolution on executive compensation.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurinia Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001600620-26-000053), on June 04, 2026, and is solely responsible for the information contained therein.